209 related articles for article (PubMed ID: 38252439)
1. Antipsychotics and the QTc Interval During Delirium in the Intensive Care Unit: A Secondary Analysis of a Randomized Clinical Trial.
Stollings JL; Boncyk CS; Birdrow CI; Chen W; Raman R; Gupta DK; Roden DM; Rivera EL; Maiga AW; Rakhit S; Pandharipande PP; Ely EW; Girard TD; Patel MB
JAMA Netw Open; 2024 Jan; 7(1):e2352034. PubMed ID: 38252439
[TBL] [Abstract][Full Text] [Related]
2. Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness.
Girard TD; Exline MC; Carson SS; Hough CL; Rock P; Gong MN; Douglas IS; Malhotra A; Owens RL; Feinstein DJ; Khan B; Pisani MA; Hyzy RC; Schmidt GA; Schweickert WD; Hite RD; Bowton DL; Masica AL; Thompson JL; Chandrasekhar R; Pun BT; Strength C; Boehm LM; Jackson JC; Pandharipande PP; Brummel NE; Hughes CG; Patel MB; Stollings JL; Bernard GR; Dittus RS; Ely EW;
N Engl J Med; 2018 Dec; 379(26):2506-2516. PubMed ID: 30346242
[TBL] [Abstract][Full Text] [Related]
3. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial.
Girard TD; Pandharipande PP; Carson SS; Schmidt GA; Wright PE; Canonico AE; Pun BT; Thompson JL; Shintani AK; Meltzer HY; Bernard GR; Dittus RS; Ely EW;
Crit Care Med; 2010 Feb; 38(2):428-37. PubMed ID: 20095068
[TBL] [Abstract][Full Text] [Related]
4. Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano RJ; O'Gorman C; Harrigan RH
Clin Ther; 2010 Mar; 32(3):472-91. PubMed ID: 20399985
[TBL] [Abstract][Full Text] [Related]
5. Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.
Miceli JJ; Tensfeldt TG; Shiovitz T; Anziano R; O'Gorman C; Harrigan RH
Pharmacotherapy; 2010 Feb; 30(2):127-35. PubMed ID: 20099987
[TBL] [Abstract][Full Text] [Related]
6. Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.
Camm AJ; Karayal ON; Meltzer H; Kolluri S; O'Gorman C; Miceli J; Tensfeldt T; Kane JM
CNS Drugs; 2012 Apr; 26(4):351-65. PubMed ID: 22452529
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
Greco KE; Tune LE; Brown FW; Van Horn WA
J Clin Psychiatry; 2005 Jul; 66(7):928-9. PubMed ID: 16013910
[TBL] [Abstract][Full Text] [Related]
8. Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical Trial.
van den Boogaard M; Slooter AJC; Brüggemann RJM; Schoonhoven L; Beishuizen A; Vermeijden JW; Pretorius D; de Koning J; Simons KS; Dennesen PJW; Van der Voort PHJ; Houterman S; van der Hoeven JG; Pickkers P; ; van der Woude MCE; Besselink A; Hofstra LS; Spronk PE; van den Bergh W; Donker DW; Fuchs M; Karakus A; Koeman M; van Duijnhoven M; Hannink G
JAMA; 2018 Feb; 319(7):680-690. PubMed ID: 29466591
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study.
Devlin JW; Roberts RJ; Fong JJ; Skrobik Y; Riker RR; Hill NS; Robbins T; Garpestad E
Crit Care Med; 2010 Feb; 38(2):419-27. PubMed ID: 19915454
[TBL] [Abstract][Full Text] [Related]
10. Antipsychotics for the prevention and treatment of delirium in the intensive care unit: what is their role?
Devlin JW; Skrobik Y
Harv Rev Psychiatry; 2011; 19(2):59-67. PubMed ID: 21425934
[TBL] [Abstract][Full Text] [Related]
11. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.
Tisdale JE; Rasty S; Padhi ID; Sharma ND; Rosman H
J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558
[TBL] [Abstract][Full Text] [Related]
12. Agreement between ICU clinicians and electrophysiology cardiologists on the decision to initiate a QTc-interval prolonging medication in critically ill patients with potential risk factors for torsade de pointes: a comparative, case-based evaluation.
Fongemie JM; Al-Qadheeb NS; Estes NA; Roberts RJ; Temtanakitpaisan Y; Ruthazer R; Devlin JW
Pharmacotherapy; 2013 Jun; 33(6):589-97. PubMed ID: 23529904
[TBL] [Abstract][Full Text] [Related]
13. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature.
Lawrence KR; Nasraway SA
Pharmacotherapy; 1997; 17(3):531-7. PubMed ID: 9165555
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Management of Delirium in the Intensive Care Unit: A Randomized Pragmatic Clinical Trial.
Khan BA; Perkins AJ; Campbell NL; Gao S; Farber MO; Wang S; Khan SH; Zarzaur BL; Boustani MA
J Am Geriatr Soc; 2019 May; 67(5):1057-1065. PubMed ID: 30681720
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of haloperidol to decrease the burden of delirium in adult critically ill patients: the EuRIDICE randomized clinical trial.
Smit L; Slooter AJC; Devlin JW; Trogrlic Z; Hunfeld NGM; Osse RJ; Ponssen HH; Brouwers AJBW; Schoonderbeek JF; Simons KS; van den Boogaard M; Lens JA; Boer DP; Gommers DAMPJ; Rietdijk WJR; van der Jagt M;
Crit Care; 2023 Oct; 27(1):413. PubMed ID: 37904241
[TBL] [Abstract][Full Text] [Related]
16. Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium.
Vandael E; Vandenberk B; Vandenberghe J; Spriet I; Willems R; Foulon V
Int J Clin Pharm; 2016 Apr; 38(2):310-20. PubMed ID: 26749342
[TBL] [Abstract][Full Text] [Related]
17. Interventions for preventing intensive care unit delirium in adults.
Herling SF; Greve IE; Vasilevskis EE; Egerod I; Bekker Mortensen C; Møller AM; Svenningsen H; Thomsen T
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD009783. PubMed ID: 30484283
[TBL] [Abstract][Full Text] [Related]
18. Ziprasidone in the management of schizophrenia : the QT interval issue in context.
Taylor D
CNS Drugs; 2003; 17(6):423-30. PubMed ID: 12697001
[TBL] [Abstract][Full Text] [Related]
19. Preventing ICU Subsyndromal Delirium Conversion to Delirium With Low-Dose IV Haloperidol: A Double-Blind, Placebo-Controlled Pilot Study.
Al-Qadheeb NS; Skrobik Y; Schumaker G; Pacheco MN; Roberts RJ; Ruthazer RR; Devlin JW
Crit Care Med; 2016 Mar; 44(3):583-91. PubMed ID: 26540397
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial.
Agar MR; Lawlor PG; Quinn S; Draper B; Caplan GA; Rowett D; Sanderson C; Hardy J; Le B; Eckermann S; McCaffrey N; Devilee L; Fazekas B; Hill M; Currow DC
JAMA Intern Med; 2017 Jan; 177(1):34-42. PubMed ID: 27918778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
